Transthyretin (TTR) drugs for Transthyretin Amyloidosis with Cardiomyopathy

6 tracked Transthyretin (TTR) drugs in the Transthyretin Amyloidosis with Cardiomyopathy race. The class explanation lives on the Transthyretin (TTR) page; the full indication pipeline across every mechanism is on the Transthyretin Amyloidosis with Cardiomyopathy page.

2 approved / phase 44 Phase 3

Head-to-head evidence: Acoramidis vs Eplontersen · Acoramidis vs Vutrisiran · Cliramitug vs Eplontersen · Cliramitug vs Vutrisiran · Eplontersen vs Nexiguran ziclumeran · Eplontersen vs Nucresiran

The roster

← all Transthyretin (TTR) drugs